Coghlan, Andy
December 2012
New Scientist;12/22/2012, Vol. 216 Issue 2896/2897, p21
The article discusses the development of a process to transform adult cells into a stem cell state, focusing on induced pluripotent stem cells reverted by the researcher Shinya Yamanaka and a clinical trial planned by the biotechnology company Advanced Cell Technology Inc.


Related Articles

  • Induced Pluripotent Stem Cells. Wilson, Kitchener D.; Wu, Joseph C. // JAMA: Journal of the American Medical Association;4/28/2015, Vol. 313 Issue 16, p1613 

    The article discusses the 2006 discovery of a method for creating induced pluripotent stem cells (iPSCs) by Takahashi and Shinya Yamanaka and colleagues, which won Yamanaka a Nobel Prize in 2012. Topics include the use of pluripotency to regenerate human organs and tissues, the time consumption...

  • One Japan Stem Cell Institute Soars, One Struggles. Fox, Cynthia // Bioscience Technology;Jun2014, p1 

    The article reports on Center for iPS Cell Research and Application (CiRA) Nobel Prize winner and scientist Shinya Yamanaka in Japan. It mentions his statement over their proposed clinical trials on induced pluripotent stem cells (IPSCs). It also notes the problem of his sister institute, the...

  • Japan stem-cell trial stirs envy. Reardon, Sara; Cyranoski, David // Nature;9/18/2014, Vol. 513 Issue 7518, p287 

    The article discusses the clinical trials of induced pluripotent stem (iPS) cells. It states that the iPS cells are created by using a patient's own tissue and by inserting them in an adult's DNA cells to reprogram the cells to an embryonic-like state. The therapy was pioneered by Shinya...

  • Stem-cell pioneer banks on future therapies. Cyranoski, David // Nature;8/9/2012, Vol. 488 Issue 7410, p139 

    The article focuses on the plans of Shinya Yamanaka of Kyoto University to build stem cell bank to be used for therapeutic purposes. It says that the scheme called the Induced Pluripotent Stem (iPS) Cell Stock, gained support from the country's health ministry committee. It mentions various...

  • As STAP Papers are Retracted, A Riken Researcher Mulls Stalling World-First Trial. Fox, Cynthia // Bioscience Technology;7/2/2014, p1 

    The article reports that Riken Center for Developmental Biology (CDB) researcher Masayo Takahashi is considering suspending a part of a world-first clinical trial of induced pluripotent stem cell (iPSC). Topics discussed include the "Nature" journal's retraction of Riken CDB researchers Haruko...

  • Nobel for stem cell trick...  // New Scientist;10/13/2012, Vol. 216 Issue 2886, p6 

    The article reports that cell scientists John Gurdon and Shinya Yamanaka were awarded the 2012 Nobel prize in physiology or medicine for their research into the reprogramming of mature cells into induced pluripotent stem cells (iPSCs) which can differentiate like embryonic stem cells.

  • Gladstone investigator Shinya Yamanaka receives Millennium Technology Award.  // Biomedical Market Newsletter;8/1/2012, Vol. 21, p1 

    The article announces that Shinya Yamanaka has received Millennium Technology Award Grand Prize.

  • Melanocytes Derived from Transgene-Free Human Induced Pluripotent Stem Cells. Jones, Jennifer C; Sabatini, Karen; Liao, Xiaoyan; Tran, Ha T; Lynch, Candace L; Morey, Robert E; Glenn-Pratola, Victoria; Boscolo, Francesca S; Yang, Qinghong; Parast, Mana M; Liu, Ying; Peterson, Suzanne E; Laurent, Louise C; Loring, Jeanne F; Wang, Yu-Chieh // Journal of Investigative Dermatology;Aug2013, Vol. 133 Issue 8, p2104 

    A letter to the editor is presented on the topic related to transgene-free human induced pluripotent stem cells (hiPSC) derived melanocytes.

  • Up for grabs. Eisenstein, Michael // Nature Biotechnology;Jun2010, Vol. 28 Issue 6, p544 

    The article focuses on the patents issued to stem cell researchers for their products featuring induced pluripotent stem (iPS) cells. Stem cell researcher Shinya Yamanaka and his team from the University of Kyoto in Japan received recognition when a patent was issued for reprogramming...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics